Incapacitating solar urticaria: successful treatment with omalizumab
Abstract: Solar urticaria is a rare form of physical urticaria mediated by immunoglobulin E. The lesions appear immediately after the sun exposure, interfering with the patient's normal daily life. Omalizumab, a monoclonal anti-IgE antibody, has been recently approved for the treatment of chron...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Sociedade Brasileira de Dermatologia,
2019-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_a5d310a23f7344cda4a5d4ccfa8498d2 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Katarina Kieselova |e author |
| 700 | 1 | 0 | |a Felicidade Santiago |e author |
| 700 | 1 | 0 | |a Martinha Henrique |e author |
| 245 | 0 | 0 | |a Incapacitating solar urticaria: successful treatment with omalizumab |
| 260 | |b Sociedade Brasileira de Dermatologia, |c 2019-07-01T00:00:00Z. | ||
| 500 | |a 0365-0596 | ||
| 500 | |a 10.1590/abd1806-4841.20198109 | ||
| 520 | |a Abstract: Solar urticaria is a rare form of physical urticaria mediated by immunoglobulin E. The lesions appear immediately after the sun exposure, interfering with the patient's normal daily life. Omalizumab, a monoclonal anti-IgE antibody, has been recently approved for the treatment of chronic spontaneous urticaria, and the latest reports support its role also in the treatment of solar urticaria. Hereby, we report a case of solar urticaria refractory to conventional treatment strategies, with an excellent response to treatment with omalizumab and phototesting normalization. | ||
| 546 | |a EN | ||
| 546 | |a PT | ||
| 690 | |a Immunoglobulin E | ||
| 690 | |a Light | ||
| 690 | |a Photosensitivity disorders | ||
| 690 | |a Urticaria | ||
| 690 | |a Dermatology | ||
| 690 | |a RL1-803 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Anais Brasileiros de Dermatologia, Vol 94, Iss 3, Pp 331-333 (2019) | |
| 787 | 0 | |n http://www.scielo.br/pdf/abd/v94n3/0365-0596-abd-94-03-0331.pdf | |
| 787 | 0 | |n http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962019000300331&tlng=en | |
| 787 | 0 | |n https://doaj.org/toc/0365-0596 | |
| 856 | 4 | 1 | |u https://doaj.org/article/a5d310a23f7344cda4a5d4ccfa8498d2 |z Connect to this object online. |